Department of Neurology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku-gun, Ishikawa 920-0293, Japan.
J Clin Neurosci. 2012 Dec;19(12):1738-9. doi: 10.1016/j.jocn.2012.04.003. Epub 2012 Sep 19.
We report a patient with sporadic amyotrophic lateral sclerosis (ALS) with a novel fusion in malignant liposarcoma (FUS) gene mutation whose neurological signs were conspicuous left-sided rigidity and apraxia. A novel heterozygous guanine (G)-to-thymine (T) transition at position 1392, c.1392G>T, leading to a methionine-to-isoleucine substitution (p.Met464Ile), was found in exon13 of FUS. Re-sequencing of the genes for superoxide dismutase 1 (SOD1) and transactive response-DNA binding protein (TARDBP) revealed no mutations. The present findings suggest that this novel FUS mutation (p.Met464Ile) is related to manifestations of ALS as well as clinical features of corticobasal degeneration.
我们报告了一例散发性肌萎缩侧索硬化症(ALS)患者,其恶性脂肪肉瘤(FUS)基因发生了新的融合突变,其神经系统表现为明显的左侧僵硬和失用症。在 FUS 外显子 13 中发现了一个新的杂合鸟嘌呤(G)到胸腺嘧啶(T)的转换,c.1392G>T,导致蛋氨酸到异亮氨酸的取代(p.Met464Ile)。超氧化物歧化酶 1(SOD1)和反式激活反应 DNA 结合蛋白(TARDBP)基因的重新测序未发现突变。目前的研究结果表明,这种新的 FUS 突变(p.Met464Ile)与 ALS 的表现以及皮质基底节变性的临床特征有关。